Latest Chronic Kidney Disease (CKD) News
Chronic kidney disease found to be 58% more likely to develop in individuals with than without the sleep disorder.
New findings suggest the medication induces beneficial renal structural changes.
The drugs do not appear to prevent progression to ESRD, new meta-analysis finds.
Overall albuminuria drop may be too small for cardiovascular, renal risk protection.
Four patients would need to adhere to diet to avoid primary end point in per-protocol analysis.
Study shows benefit of initiating epoetin beta therapy at hemoglobin levels not less than 10 g/dL in non-dialysis CKD patients.
Serum total and free testosterone declined in men on hemodialysis who received a 6-month course of the drug for secondary hyperparathyroidism.
Treatment corrects anemia and improves quality of life, according to a systemic review.
Less hypoglycemia for patients weighing less than 95 kg, with no impact on potassium lowering.
New risk calculator estimates who will need dialysis in 2 to 5 years.
While study can't prove cause-and-effect, increasing damage seen as dose rises.
Decrease in age-adjusted death rates from 2000 to 2012; increase from 2012 to 2014.
Even mild AKI with rapid recovery is associated with increased risk of chronic kidney disease stage 3 or higher.
2004 to 2012 saw increase in percutaneous ventricular assist devices, intraaortic balloon pump.
Chronic Kidney Disease (CKD) Videos
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)